In Utah, the most common way a new mother dies is by her own hand. Not from hemorrhage or preeclampsia or the cardiomyopathy that haunts the obstetric literature. Suicide is the number one cause of maternal mortality in the state. And the women you would expect a decent health system to catch are the ones already in prenatal care, already on a schedule, already screened by a questionnaire that flagged a risk, and then nothing. Diagnosed and never connected to a therapist. Or diagnosed, handed a referral, and the referral never called. That is the gap.

A small team at the University of Utah thinks they have figured out how to close it, and the way they are doing it has almost nothing in common with the standard medical reflex. The intervention is not a drug. It is a prevention pathway, embedded inside the patient portal women already use to message their OB and check lab results.

Bump2Baby360 is the patient-facing piece, an evidence-based education site adapted for pregnancy and the postpartum period, built by the U of U Health team and wired directly into MyChart. It hosts mindfulness modules and cognitive-behavioral therapy strategies, the two approaches the U.S. Preventive Services Task Force gave a Grade B recommendation in 2019 for preventing perinatal depression in higher-risk pregnant and postpartum women. The counseling literature the Task Force pooled to land that grade showed a relative-risk reduction of 0.61, a 39 percent drop in the likelihood of developing perinatal depression, with a number needed to treat around fourteen. That is a stronger preventive signal than a lot of what gets prescribed in obstetrics.

Then there is the adoption math, which is where I stopped reading and started leaning forward. Among U of U Health patients booking new obstetric appointments, nearly 93 percent have MyChart, and 40 to 50 percent of active MyChart users have used Bump2Baby360. The team has not defined exactly what “used” means in that number, whether it counts a single click or sustained engagement with the modules, and that matters for any future outcomes claim. But even taken as plain access, the penetration is the kind of figure digital-health pilots usually only get inside slide decks. Pair it with the other lever, which is that when a patient screens positive on the in-MyChart questionnaire an alert lands across her chart so the next provider she sees, OB or midwife or family medicine, cannot click past it without seeing the flag, and you have something rare. A behavioral-health step that actually steps.

The reason it matters in Utah is the failure that came before it. The state’s own Department of Health and Human Services pegs the prevalence at one in eight Utah women with postpartum depression and one in three experiencing depression or anxiety somewhere across pregnancy or the postpartum period, drawn from the Pregnancy Risk Assessment Monitoring System data the state collects from new mothers directly. National numbers from the 2023 Lancet review put global prevalence around 20 percent, with the authors calling it “a neglected aspect of maternal health,” which is the kind of mild Lancet phrasing that means the public-health apparatus has been asleep at the wheel. The Utah team puts the gap more bluntly. 80 percent of women diagnosed with perinatal depression do not follow through on the treatment recommendation they are given. That number should stop you. Diagnosis without follow-through is not screening, it is paperwork. And until very recently, Utah was producing a lot of paperwork.

TREATMENT FOLLOW-THROUGH GAP
80 percentof Utah women diagnosed with perinatal depression do not connect to the recommended treatment
The number Utah's own perinatal-health team uses to describe what screening alone has failed to fix. Source: University of Utah Health

What Bump2Baby360 is not is just as important as what it is. It is not a prescribing pipeline. The default reflex when a depression screen comes back positive in pregnancy, across much of mainstream obstetrics, has been to consider an SSRI, a class of drug whose risk-benefit picture in pregnancy is still contested and whose long-term offspring effects are not well characterized. Utah scaled the other pathway. The non-drug, prevention-first pathway that already carries the USPSTF Grade B for higher-risk women, and that the system, by inertia, had been slow to put in patients’ hands. That this one got built is a credit to the nurse-scientists who pushed it, Gwen Latendresse and Ryoko Kausler, with OB Lauren Gimbel and operations lead Brenda Gulliver on the implementation side. The funding came from NIH NIGMS, NIH NINR, and HRSA’s Advanced Nursing Education Workforce program, the nursing-research and rural-workforce buckets, not the pharma-adjacent ones.

The expansion path is worth watching. The team piloted the screening-plus-portal model in six rural Utah health districts before the state’s DHHS picked it up and rolled it statewide, and a similar deployment is now moving into Idaho through a community health partner. Rural matters because rural is where the perinatal mental-health desert is deepest, and a phone-accessible, free, evidence-based prevention module is often the only realistic offer on the table when the nearest perinatal psychiatrist is a long drive away.

What I would watch for next is the outcomes data. The 93 percent MyChart penetration and the 40 to 50 percent portal use are access metrics, not clinical ones. The test that matters is whether scaling Bump2Baby360 statewide actually moves what started this story: whether fewer Utah women die by suicide in the year around childbirth, and whether the 80 percent treatment-followthrough gap finally narrows. Utah tried prevention before it tried more prescriptions, in a system that almost always does the reverse. That alone is a shift worth marking. The numbers will tell us whether to copy it.

Sources

  1. University of Utah @theU – Bridging Gaps in Women’s Health: Preventing Perinatal Depression
  2. U of U Health Behavioral Healthcare Network – Bridging Gaps in Women’s Health (program details, MyChart integration, adoption metrics)
  3. USPSTF – Perinatal Depression: Preventive Interventions, Grade B recommendation (2019)
  4. Utah Department of Health and Human Services – Maternal Mental Health (PRAMS-based Utah prevalence)
  5. The Lancet – Perinatal depression: a neglected aspect of maternal health (2023)
  6. TrialSite News – Utah Researchers Expand Statewide Effort to Prevent Perinatal Depression